S1UTRSP5, a short restructured RNA from SLIT1 3'UTR, mitigates mouse cardiac remodeling via enhancing SlRT1 activity

Area of Science:

• Molecular Biology
• Cardiovascular Research
• RNA Therapeutics

Background:

• 3' untranslated regions (3'UTRs) regulate mRNA, and their dysregulation is implicated in cardiac dysfunction.
• The specific roles of 3'UTRs in cardiac remodeling are not fully understood.
• Slit guidance ligand 1 (SLIT1) 3'UTR is significantly reduced in heart failure myocardium.

Purpose of the Study:

• To investigate the role of SLIT1 3'UTR in cardiac remodeling.
• To identify mechanisms by which SLIT1 3'UTR influences cardiac function.
• To explore the therapeutic potential of SLIT1 3'UTR derivatives in heart failure.

Main Methods:

• Analysis of SLIT1 3'UTR levels in heart failure patients versus healthy controls.
• Investigation of interactions between SLIT1 3'UTR fragments and microRNAs, specifically miR-34a-5p.
• In vitro and in vivo studies using a restructured RNA (S1UTRSP5) to assess its effect on cardiac remodeling pathways.

Main Results:

• SLIT1 3'UTR is significantly decreased in heart failure myocardium.
• SLIT1 3'UTR and its fragment FS1UTR specifically bind to miR-34a-5p, impacting cardiac remodeling via the miR-34a-5p/SIRT1 axis.
• S1UTRSP5, a stable RNA derived from SLIT1 3'UTR, alleviates cardiac remodeling by modulating SIRT1-related signaling pathways in cardiomyocytes, cardiac fibroblasts, and endothelial cells.

Conclusions:

• SLIT1 3'UTR plays a critical role in cardiac remodeling, partly through its interaction with miR-34a-5p.
• S1UTRSP5 acts as a potent inhibitor of miR-34a-5p, offering a novel therapeutic strategy for cardiac remodeling.
• The study elucidates novel molecular mechanisms involving S1UTRSP5, SIRT1, and downstream pathways in ameliorating cardiac dysfunction.